EPISODE · Jan 6, 2026 · 22 MIN
DESTINY-Breast09: Has HER2+ First-Line Treatment Officially Changed? - Dr. Neil Iyengar & Dr. Martin Dietrich
from Community Health Media · host Community Health Media
Recorded at SABCS 2025, Dr. Neil Iyengar and Dr. Martin Dietrich break down the data that may finally dethrone CLEOPATRA as the long-standing first-line standard for HER2-positive metastatic breast cancer.From the historic success of dual HER2 inhibition to the game-changing DESTINY-Breast09 results showing median PFS exceeding 40 months, this conversation explores what true progress looks like — and how it should change clinical practice.They dive into brain metastases risk, durability of response, toxicity management, patient selection, and why using the most effective therapy first may no longer be optional.🎧 A must-watch discussion on evidence-based change in the HER2+ treatment landscape.#HER2Positive #BreastCancer #MetastaticBreastCancer #Oncology #SABCS2025 #DESTINYBreast09 #TDXd #AntibodyDrugConjugates #ADCs #BreastOncology #CancerResearch #ClinicalTrials #PrecisionOncology #MedicalOncology #CommunityHealthMedia–Thanks for watching!Our podcasts are also available on: • Spotify - https://spotf.fi/chm-podcast • Amazon Music - https://amazn.so/chm-podcast • Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248 • Castbox - https://castbox.fm/vh/6735434 • Goodpods - https://goodpods.com/profile/chm-111066 • iHeartRadio - https://iheart.com/podcast/291542082 • Pocket Casts - https://pca.st/3ncdh11o–Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.We specialize in: • Peer to peer interviews, panels & round-tables • Curated live events & conferences • Professional in-depth content & research updates • Interactive learning modules & webinars • Live & on-demand webcasts & podcastsLearn more about us here - https://communityhealth.media
Embed this episode
Ready to play
DESTINY-Breast09: Has HER2+ First-Line Treatment Officially Changed? - Dr. Neil Iyengar & Dr. Martin Dietrich
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.